By Martha Arnold Before I retired, I worked in the pharmaceutical industry, helping drug development teams make their strongest case to the FDA for approval of their compounds across a…
Continue Reading
TMA’s Global Myositis Patient Conference – Registration Rates Increase July 1!Register Now!
By Martha Arnold Before I retired, I worked in the pharmaceutical industry, helping drug development teams make their strongest case to the FDA for approval of their compounds across a…
Continue ReadingClinical trials are an important part of the process of testing new medications and treatments to see if they are safe and effective. All medical treatments and devices must be…
Continue ReadingThe Myositis Association recognizes that the myositis patient’s best hope for a cure lies in research. TMA offers a research fellowship program to attract and encourage post-doctoral trainees (PhD and…
Continue ReadingToday, Kezar Life Sciences announced topline results from the PRESIDIO study, evaluating the efficacy and safety of zetomipzomib in dermatomyositis and polymyositis. In this study, most patients experienced a clinically…
Continue Reading